MktsMarkets

Stoke Therapeutics, Inc.
NASDAQ: STOKKey statistics
STOK News
Stories mentioning STOK from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 6,229 | 1,402 | 10,632 | 13,817 | 158,569 | 22,614 | 4,894 | 4,831 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 39,673 | 41,695 | 37,696 | 25,855 | 32,676 | 23,424 | 22,205 | 21,136 |
| Sales General & Admin | 19,974 | 16,027 | 14,653 | 12,692 | ||||
| Total Operating Expenses | 59,647 | 62,841 | 53,723 | 41,117 | 47,329 | 36,269 | 34,897 | 34,173 |
| Operating Income (Loss) | (53,418) | (61,439) | (43,091) | (27,300) | 111,240 | (13,655) | (30,003) | (29,342) |
| Interest Income | 3,420 | 3,617 | 3,466 | 3,792 | 2,890 | 2,971 | 3,545 | 3,700 |
| Interest Expense | 23.00 | 2.00 | 3.00 | 3.00 | 1.00 | (1.00) | 0.00 | 5.00 |
| Other Expense | 18.00 | (110.00) | 3.00 | 28.00 | 28.00 | 201.00 | 28.00 | (48.00) |
| Pretax Income | (50,003) | (39,625) | (23,483) | 114,157 | (26,430) | (25,695) | ||
| Tax Provision | 0.00 | 0.00 | (1,278) | 0.00 | 1,278 | 0.00 | 0.00 | |
| Net Income (Loss) | (50,003) | (57,934) | (38,347) | (23,483) | 112,879 | (10,482) | (26,430) | (25,695) |
| Earnings Per Share (Basic) | (0.79) | (0.98) | (0.65) | (0.40) | 1.95 | (0.19) | (0.47) | (0.46) |
| Earnings Per Share (Diluted) | (0.79) | (0.98) | (0.65) | (0.40) | 1.90 | (0.19) | (0.47) | (0.46) |
| Weighted Average Shares Outstanding (Basic) | 63,064 | 59,219 | 58,612 | 58,354 | 57,863 | 54,009 | 56,341 | 55,766 |
| Weighted Average Shares Outstanding (Diluted) | 63,064 | 59,219 | 58,612 | 58,354 | 59,399 | 54,009 | 56,341 | 55,766 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About STOK
Stoke Therapeutics, Inc. (NASDAQ: STOK) is a stock listed on the Nasdaq Stock Market under the ticker symbol STOK. It last traded at $27.31 (Nov 18, 2026, 1:41 PM ET), up 3.4% on the day. That gives Stoke Therapeutics a market capitalisation of $1.7B.
Over the past 52 weeks STOK has traded between $22.05 and $40.22.
Revenue for the quarter ended Mar 31, 2026 was $6.2M; a net loss of $50.0M. Revenue was down 96.1% from $158.6M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $6.2M | -$50.0M | -802.7% |
| Dec 31, 2025 | $1.4M | -$57.9M | -4132.2% |
| Sep 30, 2025 | $10.6M | -$38.3M | -360.7% |
| Jun 30, 2025 | $13.8M | -$23.5M | -170.0% |
From Stoke Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…